Answers are grounded in this paper and cite their sources.
Corrective and Preventive Action (CAPA) forms an essential element of the Pharmaceutical Quality Management System (QMS). Its primary aim is to drive continuous improvement by systematically identifying, analyzing, correcting, and preventing quality issues in processes and products. This review explains the importance of CAPA within pharmaceutical QMS, covering regulatory perspectives, implementation approaches, common challenges, and overall benefits. It also highlights how CAPA strengthens compliance with Good Manufacturing Practices (GMP) and emphasizes the need for effective root cause analysis, proper documentation, and verification of outcomes to ensure success
No takes yet. Share an insight, caveat, or question.
Gurav et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: